Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DocGo (DCGO) Other financing activities (2020 - 2022)

Historic Other financing activities for DocGo (DCGO) over the last 3 years, with Q1 2022 value amounting to $2.1 million.

  • DocGo's Other financing activities rose 51947.3% to $2.1 million in Q1 2022 from the same period last year, while for Dec 2022 it was $2.1 million, marking a year-over-year increase of 51947.3%. This contributed to the annual value of $2.1 million for FY2022, which is 51947.3% up from last year.
  • As of Q1 2022, DocGo's Other financing activities stood at $2.1 million, which was up 51947.3% from -$1.5 million recorded in Q4 2021.
  • In the past 5 years, DocGo's Other financing activities ranged from a high of $2.1 million in Q1 2022 and a low of -$1.5 million during Q4 2021
  • For the 3-year period, DocGo's Other financing activities averaged around $405297.4, with its median value being $373491.0 (2020).
  • The largest annual percentage gain for DocGo's Other financing activities in the last 5 years was 117562.68% (2021), contrasted with its biggest fall of 50102.65% (2021).
  • Over the past 3 years, DocGo's Other financing activities (Quarter) stood at $373491.0 in 2020, then crashed by 501.03% to -$1.5 million in 2021, then surged by 237.74% to $2.1 million in 2022.
  • Its Other financing activities was $2.1 million in Q1 2022, compared to -$1.5 million in Q4 2021 and $861890.0 in Q3 2021.